The Encora X1™ in a Real World Observational Study
Key facts
- Who runs it
- Encora, Inc.
- Where
- Boston, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 1 Nov 2026
- Expected to end
- Aug 2032
- Type of study
- Observational
- Treatments tested
- Encora X1
- Record updated
- 5 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age 18 years or older and able to comply with all study procedures
- A diagnosis of upper limb Essential Tremor (ET) as determined by clinical history
- A prescription for the Encora X1™
- Must have at least occasional access to a computer, tablet or smartphone, and be able to complete study questionnaires through the participant portal
- Mentally competent to understand and able to perform written, informed consent (in English only) to participate in the study
Who cannot take part
- Use of other External Upper Limb Tremor Stimulation Therapy during the course of the study
- Swollen, infected, inflamed areas, or skin eruptions, open wounds, or cancerous lesions of skin at stimulation site
- History of psoriasis, eczema or atopic dermatitis at the stimulation site
- History of peripheral neuropathy in the upper limbs, including carpal tunnel syndrome and diabetic neuropathy
- Any other medical conditions or physical or mental impairments that in the sponsor/investigator's opinion would render the participant unsuitable as a candidate for the study
- Pregnant women, or women who plan to become pregnant during their duration of the study
- Patient unable to communicate with sponsor/investigator and study staff
Where in United States
- Encora TherapeuticsBoston, United StatesContact: Lexi NoyesTaking people
About the trial
What the trial wants to find out
This research is a post-market study designed to evaluate the long-term, real-world impact of the Encora X1™ on your daily life. The Encora X1™ is a FDA-cleared, wrist-worn, non-invasive neurostimulator device that delivers personalized mechanical stimulation to aid in the relief of hand tremors in adults with essential tremor. A non-invasive device is a device that stays outside of the body. It is not implanted and does not penetrate the skin. Neurostimulation means that the device uses targeted electrical or magnetic pulses to stimulate activity in the nervous system.
Read full original descriptionShow less
This study aims to understand how it improves your ability to perform daily activities and your overall satisfaction with the device over a 36-month period. Your feedback will help researchers understand how the device is used over a long period of time in a home environment and improve the delivery of care for individuals with Essential Tremor.
The group in the trial
- Registry Participants
Treatment: Encora X1
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 5 November 2026